Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' DECHEND R' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 31 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Dechend, R; Fiebler, A; Lindschau, C; Bischoff, H; Muller, D; Park, JK; Dietz, R; Haller, H; Luft, FC
      Modulating angiotensin II-induced inflammation by HMG Co-A reductase inhibition

      AMERICAN JOURNAL OF HYPERTENSION
    2. Muller, DN; Heissmeyer, V; Dechend, R; Hampich, F; Park, JK; Fiebeler, A; Shagdarsuren, E; Theuer, J; Elger, M; Pilz, B; Breu, V; Schroer, K; Ganten, D; Dietz, R; Haller, H; Scheidereit, C; Luft, FC
      Aspirin inhibits NF-kappa B and protects from angiotensin II-induced organdamage

      FASEB JOURNAL
    3. Fiebeler, A; Schmidt, F; Muller, DN; Park, JK; Dechend, R; Bieringer, M; Shagdarsuren, E; Breu, V; Haller, H; Luft, FC
      Mineralocorticoid receptor affects AP-1 and nuclear factor-kappa B activation in angiotensin II-Induced cardiac injury

      HYPERTENSION
    4. Dechend, R; Fiebeler, A; Park, JK; Muller, DN; Theuer, J; Mervaala, E; Bieringer, M; Gulba, D; Dietz, R; Luft, FC; Haller, H
      Amelioration of angiotensin II-induced cardiac injury by a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor

      CIRCULATION
    5. Witowski, J; Thiel, A; Dechend, R; Dunkel, K; Fouquet, N; Bender, TO; Langrehr, JM; Gahl, GM; Frei, U; Jorres, A
      Synthesis of C-X-C and C-C chemokines by human peritoneal fibroblasts - Induction by macrophage-derived cytokines

      AMERICAN JOURNAL OF PATHOLOGY
    6. Muller, DN; Mervaala, EMA; Schmidt, F; Park, JK; Dechend, R; Genersch, E; Breu, V; Loffler, BM; Ganten, D; Schneider, W; Haller, H; Luft, FC
      Effect of bosentan on NF-kappa B, inflammation, and tissue factor in angiotensin II-induced end-organ damage

      HYPERTENSION
    7. Muller, DN; Dechend, R; Mervaala, EMA; Park, JK; Schmidt, F; Fiebeler, A; Theuer, J; Breu, V; Ganten, D; Haller, H; Luft, FC
      NF-kappa B inhibition ameliorates angiotensin II-induced inflammatory damage in rats

      HYPERTENSION
    8. Mervaala, E; Muller, DN; Park, JK; Dechend, R; Schmidt, F; Fiebeler, A; Bieringer, M; Breu, V; Ganten, D; Haller, H; Luft, FC
      Cyclosporin A protects against angiotensin II-induced end-organ damage in double transgenic rats harboring human renin and angiotensinogen genes

      HYPERTENSION
    9. Park, JK; Muller, DN; Mervaala, EMA; Dechend, R; Fiebeler, A; Schmidt, F; Bieringer, M; Schafer, O; Lindschau, C; Schneider, W; Ganten, D; Luft, FC; Haller, H
      Cerivastatin prevents angiotensin II-induced renal injury independent of blood pressure- and cholesterol-lowering effects

      KIDNEY INTERNATIONAL
    10. Dechend, R; Homuth, V; Wallukat, G; Kreuzer, J; Park, JK; Theuer, J; Juepner, A; Gulba, DC; Mackman, N; Haller, H; Luft, FC
      AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor

      CIRCULATION
    11. Muller, DN; Mervaala, EMA; Dechend, R; Fiebeler, A; Park, JK; Schmidt, F; Theuer, J; Breu, V; Mackman, N; Luther, T; Schneider, W; Gulba, D; Ganten, D; Haller, H; Luft, FC
      Angiotensin II (AT(1)) receptor blockade reduces vascular tissue factor inangiotensin II-induced cardiac vasculopathy

      AMERICAN JOURNAL OF PATHOLOGY
    12. Dechend, R; Hirano, F; Lehmann, K; Heissmeyer, V; Ansieau, S; Wulczyn, FG; Scheidereit, C; Leutz, A
      The Bcl-3 oncoprotein acts as a bridging factor between NF-kappa B/Rel andnuclear co-regulators

      ONCOGENE
    13. Luft, FC; Mervaala, E; Muller, DN; Gross, V; Schmidt, F; Park, JK; Schmitz, C; Lippoldt, A; Breu, V; Dechend, R; Dragun, D; Schneider, W; Ganten, D; Haller, H
      Hypertension-induced end-organ damage - A new transgenic approach to an old problem

      HYPERTENSION
    14. Dechend, R; Maass, M; Gieffers, J; Dietz, R; Scheidereit, C; Leutz, A; Gulba, DC
      Chlamydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF-kappa B and induces tissue factor and PAI-1 expression - A potential link to accelerated arteriosclerosis

      CIRCULATION
    15. GULBA DC; PRAUS M; DECHEND R; HAUCK S; MAHLER M; ZITVZ R; BALDUS B; MULLER W; DIETZ R
      UPDATE ON THE TOXICOLOGY AND PHARMACOLOGY OF RDSPA ALPHA-1 (BAT-PA) IN ANIMALS AND HUMANS

      Fibrinolysis & proteolysis
    16. ANSIEAU S; KOWENZLEUTZ E; DECHEND R; LEUTZ A
      B-MYB, A REPRESSED TRANSACTIVATING PROTEIN

      Journal of molecular medicine
    17. GULBA DC; TANSWELL P; DECHEND R; SOSADA M; WEIS A; WAIGAND J; UHLICH F; HAUCK S; JOST S; RAFFLENBEUL W; LICHTLEN PR; DIETZ R
      60-MINUTE ALTEPLASE PROTOCOL - A NEW ACCELERATED RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR REGIMEN FOR THROMBOLYSIS IN ACUTE MYOCARDIAL-INFARCTION

      Journal of the American College of Cardiology
    18. GROSS CM; KRAMER J; WAIGAND J; UHLICH F; SCHRODER G; THALHAMMER C; DECHEND R; GULBA DC; DIETZ R
      STENT IMPLANTATION IN PATIENTS WITH SUPERIOR VENA-CAVA SYNDROME

      American journal of roentgenology
    19. SIMOONS ML; RUTSCH W; VAHANIAN A; ADGEY J; MASERI A; VASSANELLI C; COL J; ADELMAN A; MACAYA C; MILLER H; DEBOER MJ; MCCLOSKEY R; WEISMAN H; VERSTRAETE M; DEBONO D; SWEDBERG K; LESSAFRE E; SCHOTSMANS P; TIJSSEN J; BAR F; DECKERS JW; PIEK JJ; KLOOTWIJK APJ; BLOCK P; CATS VM; BRUGGELING W; JONKMAN F; VANDERMEER P; UMANS V; FOLEY D; ANSINK T; KEANE D; SANE D; KOUDSTAAL P; VANDENBRAND MJBM; LAARMAN GJ; HENDRICKX G; DESCHEERDER I; STEG PG; BEATT K; VANPAPENDRECHT MH; LENDERINK T; MALBRAIN S; PAUL J; DECRAEN T; CABACOWIC S; SCHAIBLE T; ANDERSON K; WANG A; FITZPATRICK S; DANIELS M; POULUSSEN T; DEGRAFF J; DIJKHUIZEN M; VERHAMME K; NELISSEN I; GIBBS M; MARRON S; LOCHU S; GUIOT C; FERRARI P; VIZZOTTO A; ALEMANY A; MALTILLO E; HOFFMANN S; STAHL L; KAFKA D; SURYAPRANATA H; LIEM AL; VELSINK G; VANDERWIEKEN R; EZECHIELS JP; ZONNEVELD S; VANDENBRAND M; VANDERZWAAN C; KINT PP; MICHELS RM; BONMIER J; VANDERKERKHOF I; HANEKAMP C; PEELS J; DROK L; DENHEIJER P; PLOKKER T; MAST EG; MARQUEZ K; VANDENBOS AA; CHIN U; CORNEL JH; ARNOLD A; GARBARZ E; NALLET O; FARRAH B; CARRIE D; PUEL J; JEAN M; CHARBONNIER B; PACOURET G; RAYNAUD R; BERTRAND B; VANZETTO G; GROLLIER G; VALETTE B; THERY C; LABLANCHE JM; DUCLOS F; COSTE P; BEAUFILS P; EIFERMAN E; DAUBERT C; LECLERCQ C; JULIARD JJM; BASSAND JP; MENEVEAU N; GUERMONPREZ JL; VROLIX M; VANLIERDE J; JACOBS S; BOLAND J; SAAT G; BAUMANS P; STAELENS F; DEBRUYNE B; TAEYMANS Y; GHEERAERT P; ALSCHWAFI K; VANDENHEUVEL P; ROGIERS R; CASTADOT M; DEWIT E; GULBA D; DECHEND R; CHRISTOW S; SIMON R; ALMOKTHARI N; VONDAHL J; JANSSENS U; HAUDE M; BAUMGART D; KARSCH KR; MAIER R; BRUNCKHORST C; REIFART N; KRAJCAR M; RUPPRECHT HJ; COBAUGH M; HERNANDEZANTOLIN R; SEGOVIA J; GARCIA P; CEQUIR A; ESPLUGAS E; GOMEZHOSPITAL J; MAURI J; ANGEL J; BALLESTER R; DELATASSA CM; BARRIALES F; AUGE J; GARCIA J; MELGARES R; KHAN M; JOHNSTON P; MCKAY Y; BEEN M; KAHN A; ILSLEY C; EWAN A; REID D; MCDERMOTT A; WARD D; BULLER N; BALCON R; ZARDINI P; LOSCHIAVO I; CASARI A; PITI A; COSTALUNGA A; REPETTO S; CARELLA S; MARZILLI M; FEDELE S; CHIOIN R; REIMERS B; MAZZARI A; SPECCHIA G; CHIARIELLO M; SHEPPS D; SCLAROVSKI S; GAL B; CASPI A; AYZENBERG O; SHARIR T; HOD H; BUSER P; PFISTERER M; RITZ R; BERTEL O; ROHNER F; DUCAS J; SHICK U; CHEUNG P; CHISHOLM R; COHEN E; GOMEZ RS; FERREIRA J; MUHLBERGER V
      RANDOMIZED PLACEBO-CONTROLLED TRIAL OF ABCIXIMAB BEFORE AND DURING CORONARY INTERVENTION IN REFRACTORY UNSTABLE ANGINA - THE CAPTURE STUDY

      Lancet
    20. DECHEND R; MO X; SCHULZ W; GROSS M; PRAUS M; DIETZ R; GULBA DC
      THROMBIN RECEPTOR AND UROKINASE-TYPE PLASMINOGEN-ACTIVATOR ARE COLOCALIZED IN VASCULAR SMOOTH-MUSCLE CELLS DERIVED FROM HUMAN CAROTID ATHEROSCLEROTIC PLAQUES

      Fibrinolysis
    21. GULBA DC; GROSS M; DECHEND R; LUFT F; SOSADA M; FREY U; DIETZ R
      THROMBOLYTIC THERAPY IN RENAL ARTERIAL EM BOLISM - CASE-REPORT WITH LITERATURE-REVIEW

      Der Internist
    22. MO XM; DECHEND R; KOWENZLEUTZ E; DIETZ R; LEUTZ A; GULBA DC
      DOSE-DEPENDENT INHIBITION OF APOPTOSIS OF HUMAN AORTIC SMOOTH-MUSCLE CELLS (HASMC) BY ANTIOXIDANTS

      Circulation
    23. FRIEDRICH MG; DECHEND R; BARKOWSKI A; JUNGNICKEL K; BACHER P; WELZEL D; DIETZ R; GULBA DC
      PREVENTION OF RESTENOSIS AFTER PTCA WITH LONG-TERM TREATMENT OF LOW-MOLECULAR-WEIGHT HEPARIN - RESULTS OF A PILOT-STUDY

      Thrombosis and haemostasis
    24. DECHEND R; SELBIG D; PRAUS M; HAUCK S; DIETZ R; GULBA DC
      LONG-TERM THROMBOLYTIC THERAPY WITH 2 NEW RT-PA REGIMEN IN SUBMASSIVEPULMONARY-EMBOLISM - RESULTS OF A PILOT-STUDY

      Thrombosis and haemostasis
    25. GULBA DC; DECHEND R; FRIEDRICH MG; FRIEDRICH M; DIETZ R; LUFT FC
      THROMBOLYTIC THERAPY IN RENAL ARTERIAL EMBOLISM

      Thrombosis and haemostasis
    26. DECHEND R; GULBA DC; HAUCK S; DIETZ R
      THE PROBLEM OF REOCCLUSION AND RESTENOSIS - CLINICAL ASPECTS

      Fibrinolysis
    27. HAUCK S; FRIEDRICH M; DECHEND R; GULBA DC; DIETZ R
      CONTINUOUS 3-DIMENSIONAL VECTORCARDIOGRAPHY, A VALUABLE TOOL FOR ONLINE ISCHEMIA MONITORING

      Fibrinolysis
    28. PRAUS M; MO XM; GROSSE Y; BALDUS B; MORSER J; DECHEND R; GULBA DC
      A NOVEL THROMBOMODULIN BASED PLASMA ASSAY UNCOVERS ABNORMALITIES IN THE PROTEIN-S PROTEIN-C ANTICOAGULANT PATHWAY DISTINCT FROM RESISTANCE TO ACTIVATED PROTEIN-C IN MYOCARDIAL-INFARCTION PATIENTS

      Circulation
    29. GULBA DC; DECHEND R
      THROMBOLYSIS IN THROMBOEMBOLIC DISEASES

      Annals of hematology
    30. DECHEND R; HAUCK S; EICHHORN J; GOEDECKE W; PRAUS M; SCHULZMENGER J; BARTHELS M; DIETZ R; GULBA DC
      EFFECTS OF LOW-MOLECULAR-WEIGHT AND HIGH-MOLECULAR-WEIGHT HEPARIN ON THE INTRINSIC AND EXTRINSIC ENDOGENOUS FIBRINOLYTIC SYSTEM

      Fibrinolysis
    31. DECHEND R; THODE H; MULLER T; EISERT WE; DIETZ R; GULBA DC
      FRAGMENTATION-PATTERN OF FIBRINOGEN DURING THROMBOLYSIS IN ACUTE MYOCARDIAL-INFARCTION WITH FIBRIN-SPECIFIC PLASMINOGEN ACTIVATORS - DETECTION OF HIGH-MOLECULAR-WEIGHT FIBRINOGEN DEGRADATION PRODUCTS

      Fibrinolysis


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 16/01/21 alle ore 22:56:30